© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
The HCPLive low-T page is a comprehensive resource for clinical news and insights on low testosterone. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for low-T, and more.
March 31, 2020
New data from ENDO 2020 suggests the presence of erectile dysfunction and sexual symptoms was linked to increased risk of death.
January 11, 2020
A recent analysis of participants in the NHANES database found low fat and Mediterranean diets were linked to lower serum testosterone levels in men.
January 07, 2020
The American College of Physicians has released guidelines, which include 4 new recommendations, for the treatment of age-related low testosterone in men.
March 27, 2019
Jatenzo's label will be marketed with a boxed warning stating it can cause risen blood pressure, thereby increasing heart attack, stroke, and cardiovascular death risks.
October 02, 2018
XYOSTED's approval comes nearly a year following Antares first received a Complete Response Letter from the FDA for its application.
May 10, 2018
TLANDO is being investigated for the treatment of adult men with deficiencies of endogenous testosterone.
January 11, 2018
Lipocene's TLANDO was recommended against by a vote of 13-6.
May 30, 2017
Experts caution duration of testosterone replacement therapy.
April 01, 2017
The type 1 diabetes patients who were continuously administered testosterone treatment showed improvements in glycemic control as well as massive improvements in their weight loss, since testosterone increases lean body mass.
Farid Saad, DVM, PhD, Bayer Pharma AG learned that the men with type 1 diabetes did experience benefits of long-term testosterone therapy â€“ they showed improvements in their underlying diseases.